Mitotic catastrophe and other cellular instability events in sodium valproate-treated HeLa cells

Authors:
Preprint
Publisher website
Google Scholar
Abstract
Valproic acid/sodium valproate (VPA) is a widely prescribed anticonvulsant and has also been used against certain tumor cells. It is a potent modulator of gene expression. Its ability to induce apoptosis has been well documented in HeLa cells. However, another form of cell death - mitotic catastrophe - has not yet been explored in VPA-treated HeLa cells. Here, we investigated the effects of VPA treatment on mitotic catastrophe characteristics, including morphological features and their frequencies, fluorescence intensity signals of caspase-2 and p53, and the expression and abundance of DNMT1 and DNMT3B. An increased frequency of mitotic catastrophe was observed not only morphologically, but also through enhanced induction of caspase-2, involvement of p53, at least under more drastic VPA treatment, but without a decrease in DNMT1 or DNMT3B levels. Additionally, enhancement of mitotic catastrophe coincided with a reduction in mitotic chromosome abnormalities. Increased DNMT3B expression following VPA action, may be favored by previously reported chromatin decondensation induced by this drug. Enhanced CpG methylation of specific DNA sites could thus be promoted. In conclusion, VPA was shown to trigger metabolic pathways linked to different forms of cell death in HeLa cells, supporting its oncosuppressive potential.
Funding Information
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (105467/2022-7)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (105626/2022-8)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (304589/2024-1)

This publication has 36 references indexed in Scilit: